Gary W. Wood

Gary W. Wood founded TVAX Biomedical in 2004 and currently serves as Chief Scientific Officer and Chairman of the Board of Directors. He served as President and CEO of the company from the company’s inception until December 2012. Dr. Wood is the inventor and principal developer of the TVAX Immunotherapy® technology. Dr. Wood guided the development of TVAX Immunotherapy from concept through its most recent human clinical trials. Dr. Wood organized and coordinated the Phase 1 / 2 clinical trials performed at the University of Kansas Medical Center and at Wayne State University and managed the scientific/clinical teams that performed the trials. Dr. Wood was a Professor of Pathology, Director of the Diagnostic Immunology Laboratory, and Director of the Cancer Immunotherapy Laboratory at KU Medical Center. Dr. Wood also was a Professor of Medicine and Director of the Cancer Immunotherapy Laboratory at Wayne State University. Dr. Wood has a B.A. from Kalamazoo College and a Ph.D. from the State University of New York at Buffalo.